Clinical Trial Update: Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen [Phase 3]

View source ↗

Summary

This document reports the completed extension of a Phase 3 study evaluating allogeneic hematopoietic stem cell transplantation from haplotype-mismatch related o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Allogeneic hematopoietic stem cell transplantation

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Acute Leukemia, Non Hodgkin Lymphoma | Phase 3 | Status: COMPLETED